Growth Metrics

Family Office Of America (FOFA) Receivables (2025 - 2026)

Family Office Of America recorded quarterly Receivables of $267666.0 in Q1 2026, up 258.01% quarter-over-quarter from $74764.0 in Q4 2025.

Family Office Of America's Receivables history runs 2 years deep, the most recent figure standing at $267666.0 for Q1 2026.

  • In Q1 2026, Receivables changed N/A year-over-year to $267666.0; the TTM figure through Mar 2026 stood at $267666.0 (changed N/A YoY), while the FY2025 annual figure was $74764.0, changed N/A from the prior year.
  • Receivables came in at $267666.0 for Q1 2026 at Family Office Of America, up from $74764.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $267666.0 in Q1 2026 to a low of $74764.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 Family Office Of America - - 783,126.00 267,666.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 267,666.00
Dec 31, 2025 74,764.00